NK cell-like behavior of Vα14i NK T cells during MCMV infection

PLoS Pathogens

Volumn 4, Issue 7, 2008, Pages

  Wesley, Johnna D ^a   Tessmer, Marlowe S ^a   Chaukos, Deanna ^a   Brossay, Laurent ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD1D ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 2 RECEPTOR ALPHA; T BOX TRANSCRIPTION FACTOR; T BOX TRANSCRIPTION FACTOR TBX21; T-BOX TRANSCRIPTION FACTOR TBX21;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; INTERFERON PRODUCTION; LYMPHOCYTE PROLIFERATION; MORTALITY; MOUSE; NATURAL KILLER T CELL; NONHUMAN; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY; ANIMAL; BETAHERPESVIRINAE; C57BL MOUSE; CELL COUNT; GENE SILENCING; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBPOPULATION; METABOLISM; MOUSE MUTANT; NATURAL KILLER CELL; PHYSIOLOGY; T LYMPHOCYTE SUBPOPULATION; VIROLOGY; VIRUS REPLICATION;

BACTERIA (MICROORGANISMS); MAIZE CHLOROTIC MOTTLE VIRUS; MURID HERPESVIRUS 1; MUS;

ANIMALS; CELL COUNT; GENE SILENCING; IMMUNITY, NATURAL; INTERFERON TYPE II; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; LYMPHOCYTE SUBSETS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MUROMEGALOVIRUS; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS; VIRUS REPLICATION;

EID: 48249103545     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000106     Document Type: Article

References (62)

1. Lussier G (1975) Murine cytomegalovirus (MCMV). Adv Vet Sci Comp Med 19: 223-247.
2. Hanson LK, Slater JS, Karabekian Z, Virgin HWt, Biron CA, et al. (1999) Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol 73: 5970-5980.
3. Bolger G, Lapeyre N, Rheaume M, Kibler P, Bousquet C, et al. (1999) Acute murine cytomegalovirus infection: a model for determining antiviral activity against CMV induced hepatitis. Antiviral Res 44: 155-165.
4. Orange JS, Biron CA (1996) Characterization of early IL-12, IFN-alphabeta, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 156: 4746-4756.
5. Biron CA, Su HC, Orange JS (1996) Function and Regulation of Natural Killer (NK) Cells during Viral Infections: Characterization of Responses in Vivo. Methods 9: 379-393.
6. Orange JS, Wang B, Terhorst C, Biron CA (1995) Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182: 1045-1056.
7. Daniels KA, Devora G, Lai WC, O'Donnell CL, Bennett M, et al. (2001) Murine cytomegalovirus is regulated by a discrete subset of natural killer cells reactive with monoclonal antibody to Ly49H. J Exp Med 194: 29-44.
8. Loh J, Chu DT, O'Guin AK, Yokoyama WM, Virgin HWt (2005) Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver. J Virol 79: 661-667.
9. van Dommelen SL, Sumaria N, Schreiber RD, Scalzo AA, Smyth MJ, et al. (2006) Perforin and granzymes have distinct roles in defensive immunity and immunopathology. Immunity 25: 835-848.
10. Vidal SM, Lanier LL (2006) NK cell recognition of mouse cytomegalovirus-infected cells. Curr Top Microbiol Immunol 298: 183-206.
11. Doherty DG, O'Farrelly C (2001) Dendritic cells: regulators of hepatic immunity or tolerance? J Hepatol 34: 156-160.
12. Crispe IN (2003) Hepatic T cells and liver tolerance. Nat Rev Immunol 3: 51-62.
13. Eberl G, Lees R, Smiley ST, Taniguchi M, Grusby MJ, et al. (1999) Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J Immunol 162: 6410-6419.
14. Matsuda JL, Gapin L, Sidobre S, Kieper WC, Tan JT, et al. (2002) Homeostasis of V alpha 14i NKT cells. Nat Immunol 3: 966-974.
15. Kronenberg M, Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2: 557-568.
16. Kronenberg M (2004) Toward an Understanding of NKT Cell Biology: Progress and Paradoxes. Annu Rev Immunol 23: 877-900.
17. Lantz O, Bendelac A (1994) An invariant T cell receptor alpha chain is used by a unique subset of major histocompatibility complex class I-specific CD4+ and CD4-8- T cells in mice and humans. J Exp Med 180: 1097-1106.
18. Porcelli S, Yockey CE, Brenner MB, Balk SP (1993) Analysis of T cell antigen receptor (TCR) expression by human peripheral blood CD4-8- alpha/beta T cells demonstrates preferential use of several V beta genes and an invariant TCR alpha chain. J Exp Med 178: 1-16.
19. Carnaud C, Lee D, Donnars O, Park SH, Beavis A, et al. (1999) Cutting edge: Cross-talk between cells of the innate immune system: NKT cells rapidly activate NK cells. J Immunol 163: 4647-4650.
20. Wesley JD, Robbins SH, Sidobre S, Kronenberg M, Terrizzi S, et al. (2005) Cutting edge: IFN-gamma signaling to macrophages is required for optimal Valpha14i NK T/NK cell cross-talk. J Immunol 174: 3864-3868.
21. Tomura M, Yu WG, Ahn HJ, Yamashita M, Yang YF, et al. (1999) A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system. J Immunol 163: 93-101.
22. Kitamura H, Ohta A, Sekimoto M, Sato M, Iwakabe K, et al. (2000) alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells. Cell Immunol 199: 37-42.
23. Kakimi K, Guidotti LG, Koezuka Y, Chisari FV (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192: 921-930.
24. Shimosaka A (2002) Role of NKT cells and alpha-galactosyl ceramide. Int J Hematol 76 Suppl 1: 277-279.
25. van Dommelen SL, Tabarias HA, Smyth MJ, Degli-Esposti MA (2003) Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells. J Virol 77: 1877-1884.
26. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M, Hong S, Bruna-Romero O, et al. (2000) alpha -galactosylceramide-activated Valpha 14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci U S A 97: 8461-8466.
27. Ishikawa H, Hisaeda H, Taniguchi M, Nakayama T, Sakai T, et al. (2000) CD4(+) v(alpha)14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 12: 1267-1274.
28. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, et al. (2001) Monocyte chemoattractant protein-1-dependent increase of V alpha 14 NKT cells in lungs and their roles in Th1 response and host defense in cryptococcal infection. J Immunol 167: 6525-6532.
29. Chackerian A, Alt J, Perera V, Behar SM (2002) Activation of NKT cells protects mice from tuberculosis. Infect Immun 70: 6302-6309.
30. Kawakami K, Kinjo Y, Uezu K, Yara S, Miyagi K, et al. (2002) Minimal contribution of Valpha14 natural killer T cells to Th1 response and host resistance against mycobacterial infection in mice. Microbiol Immunol 46: 207-210.
31. Mattner J, Debord KL, Ismail N, Goff RD, Cantu C, 3rd, et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434: 525-529.
32. Kinjo Y, Tupin E, Wu D, Fujio M, Garcia-Navarro R, et al. (2006) Natural killer T cells recognize diacylglycerol antigens from pathogenic bacteria. Nat Immunol 7: 978-986.
33. Sanchez DJ, Gumperz JE, Ganem D (2005) Regulation of CD1d expression and function by a herpesvirus infection. J Clin Invest 115: 1369-1378.
34. Webb TJ, Litavecz RA, Khan MA, Du W, Gervay-Hague J, et al. (2006) Inhibition of CD1d1-mediated antigen presentation by the vaccinia virus B1R and H5R molecules. Eur J Immunol 36: 2595-2600.
35. Yuan W, Dasgupta A, Cresswell P (2006) Herpes simplex virus evades natural killer T cell recognition by suppressing CD1d recycling. Nat Immunol 7: 835-842.
36. Hobbs JA, Cho S, Roberts TJ, Sriram V, Zhang J, et al. (2001) Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. J Virol 75: 10746-10754.
37. Lin Y, Roberts TJ, Wang CR, Cho S, Brutkiewicz RR (2005) Long-term loss of canonical NKT cells following an acute virus infection. Eur J Immunol 35: 879-889.
38. Muller U, Steinhoff U, Reis LF, Hemmi S, Pavlovic J, et al. (1994) Functional role of type I and type II interferons in antiviral defense. Science 264: 1918-1921.
39. Orange JS, Wang B, Terhorst C, Biron CA (1995) Requirement for natural killer cell-produced interferon g in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration. J Exp Med 182: 1045-1056.
40. Tay CH, Yu LY, Kumar V, Mason L, Ortaldo JR, et al. (1999) The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. J Immunol 162: 718-726.
41. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJ, Hayakawa Y, et al. (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171: 4020-4027.
42. Kinjo Y, Wu D, Kim G, Xing GW, Poles MA, et al. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434: 520-525.
43. Orange JS, Biron CA (1996) Characterization of early IL-12, IFN-ab, and TNF effects on antiviral state and NK cell responses during murine cytomegalovirus infection. J Immunol 156: 4746-4756.
44. Tay CH, Welsh RM (1997) Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 71: 267-275.
45. Eberl G, MacDonald HR (2000) Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells. Eur J Immunol 30: 985-992.
46. Sriram V, Du W, Gervay-Hague J, Brutkiewicz RR (2005) Cell wall glycosphingolipids of Sphingomonas paucimobilis are CD1d-specific ligands for NKT cells. Eur J Immunol 35: 1692-1701.
47. Brigl M, Bry L, Kent SC, Gumperz JE, Brenner MB (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat Immunol 4: 1230-1237.
48. Barral DC, Brenner MB (2007) CD1 antigen presentation: how it works. Nat Rev Immunol 7: 929-941.
49. Wilson MT, Johansson C, Olivares-Villagomez D, Singh AK, Stanic AK, et al. (2003) The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci U S A 100: 10913-10918.
50. Nagarajan NA, Kronenberg M (2007) Invariant NKT cells amplify the innate immune response to lipopolysaccharide. J Immunol 178: 2706-2713.
51. Zucchini N, Bessou G, Robbins SH, Chasson L, Raper A, et al. (2007) Individual plasmacytoid dendritic cells are major contributors to the production of multiple innate cytokines in an organ-specific manner during viral infection. Int Immunol.
52. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, et al. (2004) Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc Natl Acad Sci U S A 101: 3516-3521.
53. Krug A, French AR, Barchet W, Fischer JA, Dzionek A, et al. (2004) TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21: 107-119.
54. Paget C, Mallevaey T, Speak AO, Torres D, Fontaine J, et al. (2007) Activation of invariant NKT cells by toll-like receptor 9-stimulated dendritic cells requires type I interferon and charged glycosphingolipids. Immunity 27: 597-609.
55. Dorner BG, Smith HR, French AR, Kim S, Poursine-Laurent J, et al. (2004) Coordinate expression of cytokines and chemokines by NK cells during murine cytomegalovirus infection. J Immunol 172: 3119-3131.
56. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, et al. (2002) Interferon a/b and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J Exp Med 195: 517-528.
57. Orange JS, Biron CA (1996) An absolute and restricted requirement for IL-12 in natural killer cell IFN-gamma production and antiviral defense. Studies of natural killer and T cell responses in contrasting viral infections. J Immunol 156: 1138-1142.
58. Cousens LP, Orange JS, Su HC, Biron CA (1997) Interferon-a/b inhibition of interleukin 12 and interferon-gamma production in vitro and endogenously during viral infection. Proc Natl Acad Sci U S A 94: 634-639.
59. Smyth MJ, Taniguchi M, Street SE (2000) The anti-tumor activity of IL-12: mechanisms of innate immunity that are model and dose dependent. J Immunol 165: 2665-2670.
60. Smyth MJ, Crowe NY, Pellicci DG, Kyparissoudis K, Kelly JM, et al. (2002) Sequential production of interferon-g by NK1.1(+) T cells and natural killer cells is essential for the antimetastatic effect of a-galactosylceramide. Blood 99: 1259-1266.
61. Hermans IF, Silk JD, Gileadi U, Salio M, Mathew B, et al. (2003) NKT cells enhance CD4+ and CD8+ T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171: 5140-5147.
62. Fujii S, Shimizu K, Smith C, Bonifaz L, Steinman RM (2003) Activation of natural killer T cells by a-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein. J Exp Med 198: 267-279.